Amneal Pharmaceuticals (AMRX) Tax Provisions (2017 - 2026)

Amneal Pharmaceuticals' Tax Provisions history runs 10 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 83.09% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $584000.0 (down 97.72% YoY), while the FY2025 annual figure was $11.3 million, down 40.22% from the prior year.
• Tax Provisions was $2.2 million for Q1 2026 at Amneal Pharmaceuticals, down from $5.7 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $16.1 million in Q2 2025 to a low of -$23.4 million in Q3 2025.
• Historically, Tax Provisions has averaged $2.8 million across 5 years, with a median of $3.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions slumped 1064.07% in 2022, then surged 15830.43% in 2024.
• A 5-year view of Tax Provisions shows it stood at -$1.8 million in 2022, then jumped by 637.7% to $9.9 million in 2023, then slumped by 45.13% to $5.4 million in 2024, then increased by 4.41% to $5.7 million in 2025, then slumped by 61.57% to $2.2 million in 2026.
• The last three Tax Provisions figures came in at $2.2 million (Q1 2026), $5.7 million (Q4 2025), and -$23.4 million (Q3 2025), per Business Quant data.